Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefprozil Dispersible Tablets

Approval Number

国药准字H20052514

Company广州白云山医药集团股份有限公司白云山制药总厂

Registration Date

June 11, 2020

Drug Information

Generic Name

头孢丙烯分散片

Trade Name

银力舒

Brand Name

银力舒

Dosage Form

片剂

Strength

0.25g(以C18H19N3O5S计）

Drug Type

化学药品

Registration Date

June 11, 2020

Company Information

Applicant Company

Company Name广州白云山医药集团股份有限公司白云山制药总厂

Company Address

广州市白云区同和街云祥路88号

Manufacturing Company

Company Name广州白云山医药集团股份有限公司白云山制药总厂

Company Address

广州市白云区同和街云祥路88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy